Recent Articles from GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Richtech Robotics Inc. of Class Action Lawsuit and Upcoming Deadlines – RR
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ: RR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the successful completion of manufacturing of the first batch of FibroBiologics’ proprietary CYWC628 drug product that will support upcoming first-in-human clinical trials. Manufactured in accordance with Food and Drug Administration’s (FDA’s) Good Manufacturing Practices (CGMP), the drug product will be released after it successfully passes all required safety and quality testing.
By FibroBiologics, Inc. · Via GlobeNewswire · March 31, 2026
Scripps completes sale of WRTV in Indianapolis to Circle City Broadcasting
CINCINNATI, March 31, 2026 (GLOBE NEWSWIRE) -- The E.W. Scripps Company (NASDAQ: SSP) closed today on the sale of WRTV, its ABC-affiliated station in Indianapolis, to Circle City Broadcasting for $83 million.
By E.W. Scripps Company (The) · Via GlobeNewswire · March 31, 2026
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
Conference call and webcast scheduled for April 1, 2026, at 8:00 A.M. EDT / 2:00 P.M. CEST
By Nanobiotix S.A. · Via GlobeNewswire · March 31, 2026
AXIS Capital to Release First Quarter Financial Results on April 29, 2026
PEMBROKE, Bermuda, March 31, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the first quarter ended March 31, 2026 on Wednesday, April 29, 2026 after the close of the financial markets.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ramaco Resources, Inc. of Class Action Lawsuit and Upcoming Deadlines – METC
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Navan, Inc. of Class Action Lawsuit and Upcoming Deadlines – NAVN
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Navan, Inc. (“Navan” or the “Company”) (NASDAQ: NAVN) and certain of its officers and/or directors, alleging violations of the federal securities laws. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AMC Entertainment Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMC; APE
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. (“AMC” or the “Company”) (NYSE: AMC; APE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ostin Technology Group Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – OST
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. (“Ostin” or the “Company”) (NASDAQ: OST).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. (“Regenxbio” or the “Company”) (NASDAQ: RGNX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Masonite International Corporation Common Stock of Class Action Lawsuit and Upcoming Deadlines – DOOR
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Masonite International Corporation (“Masonite” or the “Company”) (NYSE: DOOR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
dLocal to Report First Quarter 2026 Financial Results
MONTEVIDEO, Uruguay, March 31, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), a leading financial technology company powering payments across emerging markets, intends to release financial results for its first fiscal quarter ended March 31, 2026 on May 14, 2026 after market close.
By DLocal Limited · Via GlobeNewswire · March 31, 2026
Banzai Reports Fourth Quarter and Full Year 2025 Financial Results
Full Year 2025 Revenue of $12.2 Million, up 169% from 2024 
By Banzai International, Inc. · Via GlobeNewswire · March 31, 2026
Trust Stamp provides a comprehensive business briefing for Q1 of 2026 reporting strong progress across multiple business geographies and verticals
Atlanta, GA, March 31, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) provided a business update for Q1 of 2026.
By Trust Stamp · Via GlobeNewswire · March 31, 2026
Trust Stamp filed its 10-K for the year ending December 31, 2025 reflecting strong growth in customer enrollments and user completions with a 33.6% year-on-year decrease in Comprehensive Operating Loss
Atlanta, GA, March 31, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced that:
By Trust Stamp · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Snowflake Inc. of Class Action Lawsuit and Upcoming Deadlines – SNOW
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Snowflake Inc. (“Snowflake” or the “Company”) (NYSE: SNOW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
CMB.TECH announces final year results
CMB.TECH ANNOUNCES FINAL YEAR RESULTS
By CMB.TECH NV. · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Paysafe Limited of Class Action Lawsuit and Upcoming Deadlines – PSFE
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
nCino Appoints Keith Kettell as Chief Revenue Officer to Lead Next Phase of Growth
WILMINGTON, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced the appointment of Keith Kettell as Chief Revenue Officer, effective April 1.
By nCino, Inc. · Via GlobeNewswire · March 31, 2026
OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference.
By OrthoPediatrics Corp. · Via GlobeNewswire · March 31, 2026
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
Management to Host Conference Call Today at 4:30 p.m. ET
By MDB Capital Holdings, LLC · Via GlobeNewswire · March 31, 2026
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD –
Rigetti Announces Novera QPU Sale to the University of Saskatchewan
The Novera QPU will be at the core of the University of Saskatchewan’s first quantum computing system
By Rigetti Computing, Inc. · Via GlobeNewswire · March 31, 2026
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
Roluperidone has been de-risked by consistent positive results in two prior pivotal trials and remains the only late-stage drug candidate for this high-need population
By Minerva Neurosciences, Inc · Via GlobeNewswire · March 31, 2026
Lesaka Webcast and Conference Call to Review Third Quarter 2026 Results
JOHANNESBURG, March 31, 2026 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (NASDAQ: LSAK, JSE: LSK) ("Lesaka") today announced it will release third quarter 2026 results after the U.S. market close on May 6, 2026. Lesaka management will host a presentation webcast and conference call on May 7, 2026, at 8:00am EDT (2:00pm SAST), followed by a live question and answer session for analysts and investors.
By Lesaka Technologies · Via GlobeNewswire · March 31, 2026
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
The American Society for Clinical Oncology to be held in Chicago May 29 – June 2, 2026
By NextCure · Via GlobeNewswire · March 31, 2026
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
-- Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval --
By Femasys Inc. · Via GlobeNewswire · March 31, 2026
Datacentrex Announces Closing of $20.17 Million Public Offering
SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses, today announced the closing of its previously announced public offering (the “Offering”) of 4,510,000 shares of common stock and 5,757,000 pre-funded warrants at a public offering price of $2.00 per share (inclusive of the pre-funded warrant exercise price of $0.01), resulting in gross proceeds of $20.17 million, before deducting placement agent fees and other related expenses.
By Datacentrex Inc. · Via GlobeNewswire · March 31, 2026
Spartacus Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 2, 2026
Austin, TX, March 31, 2026 (GLOBE NEWSWIRE) -- Spartacus Acquisition Corp. II (Nasdaq: TMTSU) (the “Company”) announced today that, commencing April 2, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “TMTS” and “TMTSW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TMTSU.”
By Spartacus Acquisition Corp. II · Via GlobeNewswire · March 31, 2026
Bond Provides Business Update Highlighting Transition from a Year of Foundational Investments to NASDAQ listing and Multichannel International Growth
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Our Bond, Inc. (“Bond”) (NASDAQ: OBAI), the creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today filed its annual report on Form 10-K with the SEC and provided a business update highlighting strong operational execution, accelerating enterprise adoption and growing global traction since its public listing on February 4, 2026. 
By Our Bond, Inc. · Via GlobeNewswire · March 31, 2026
Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum
Company expands product platform, strengthens balance sheet, advances strategic partnerships, and positions AquaRefining™ for commercial scale
By Aqua Metals · Via GlobeNewswire · March 31, 2026
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ROCKVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, reported today that Compensation Committee of the Board of Directors of MaxCyte granted inducement awards in the form of stock options to purchase an aggregate of 375,000 shares of MaxCyte’s common stock and a service-based restricted stock unit (“RSU”) award with respect to 187,500 shares of MaxCyte’s common stock to Parmeet Ahuja in connection with his appointment as Chief Financial Officer of MaxCyte. The awards were granted under the MaxCyte, Inc. 2026 Inducement Plan (the “Plan”) with a grant date of March 30, 2026 with respect to the stock option award and April 15, 2026 with respect to the RSU award, as an inducement material to Mr. Ahuja entering into employment with MaxCyte, in accordance with Nasdaq Listing Rule 5635(c)(4).
By MaxCyte, Inc · Via GlobeNewswire · March 31, 2026
ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Disease Profile
Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026
By ORIC Pharmaceuticals · Via GlobeNewswire · March 31, 2026
Digital Realty Schedules First Quarter 2026 Earnings Release and Conference Call
AUSTIN, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions, announced today that it will release financial results for the first quarter of 2026 after the market closes on Thursday, April 23, 2026. The company will host a conference call to discuss these results at 5:00 p.m. ET / 4:00 p.m. CT on Thursday, April 23, 2026. 
By Digital Realty Trust, L.P. · Via GlobeNewswire · March 31, 2026
nCino Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Exceeds All Financial Guidance MetricsACV as of January 31, 2026, $602.4M, up 17% Year-Over-YearFiscal 2026 ACV Net Retention Rate of 112%Announces $100M Accelerated Share Repurchase Program
By nCino, Inc. · Via GlobeNewswire · March 31, 2026
Howard Hughes Holdings Announces New Date of September 17 for Annual Shareholder Meeting
HHH Executive Chairman Bill Ackman and Chief Investment Officer Ryan Israel to present on the Company’s acquisition of Vantage Group Holdings, anticipated to close in Q2
By Howard Hughes Holdings Inc. · Via GlobeNewswire · March 31, 2026
Colliers Announces Voting Results
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX: CIGI; NASDAQ: CIGI) (“Colliers” or the “Company”) today announced that at its annual and special meeting of shareholders held virtually on March 31, 2026, the ten director nominees listed in Colliers’ management information circular dated February 20, 2026 (the “Circular”) were elected as directors of Colliers. Directors have been elected to serve until the close of the next annual meeting of shareholders. The detailed results of the vote are set out below.
Bank OZK Announces Date for First Quarter 2026 Earnings Release and Conference Call
LITTLE ROCK, Ark., March 31, 2026 (GLOBE NEWSWIRE) -- Bank OZK (the “Bank”) (Nasdaq: OZK) expects to report its first quarter 2026 earnings after the market closes on Tuesday, April 21, 2026. Management comments on the first quarter of 2026 will be released simultaneously with the earnings press release and financial supplement which will be available on the Bank’s investor relations website.   
By Bank OZK · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. (“PomDoctor” or the “Company”) (NASDAQ: POM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NuScale Power Corporation of Class Action Lawsuit and Upcoming Deadlines – SMR
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Revenue of $262.9 Million for Full Year 2025, Up 2% Year-Over-Year, Reflecting Contributions from New Store Openings
By Jushi Holdings Inc. · Via GlobeNewswire · March 31, 2026
Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
Company announcement – No. 6 / 2026
By Zealand Pharma · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PayPal Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – PYPL
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ: PYPL).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyndryl Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – KD
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Oracle Corporation of Class Action Lawsuit and Upcoming Deadlines – ORCL
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Oracle Corporation (“Oracle” or the “Company”) (NYSE: ORCL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
PLUG POWER CLASS ACTION DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Urges Plug Power (NASDAQ:PLUG) Investors to Contact the Firm Before the Lead Plaintiff Deadline This Friday
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Plug Power (PLUG) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2026
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Navan, Inc. (NASDAQ: NAVN) and Corcept Therapeutics Incorporated (NASDAQ: CORT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Friedman Industries, Incorporated Announces Cash Dividend
LONGVIEW, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Friedman Industries, Incorporated, (NASDAQ/GS: FRD) a Texas-based company engaged in metals processing, pipe manufacturing, and metals distribution, declared on March 31, 2026, a cash dividend of $0.04 per share on the Common Stock of the Company. The Company will pay the cash dividend on May 22, 2026 to shareholders of record at the close of business on April 24, 2026. This dividend marks the Company’s 217th consecutive quarterly cash dividend since becoming publicly traded in 1972.
By Friedman Industries Inc. · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against ODDITY Tech Ltd. and Certain Officers – ODD
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ODDITY Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv- 01951, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nektar securities between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in China Liberal Education Holdings Limited of Class Action Lawsuit and Upcoming Deadlines – CLEUF
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against China Liberal Education Holdings Limited (“CLEU” or the “Company”) (OTCMKTS: CLEUF).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Lakeland Industries, Inc. and Certain Officers – LAKE
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-01501, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Lakeland securities between December 1, 2023 and December 9, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Pinterest, Inc.and Certain Officers – PINS
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Pinterest, Inc. (“Pinterest” or the “Company”) (NYSE: PINS) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-02745, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Pinterest securities between February 7, 2025 and February 12, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Enphase Energy, Inc. and Certain Officers – ENPH
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ: ENPH) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-01380, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Enphase securities between April 22, 2025 and October 28, 2025 both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) and certain officers.   The class action, filed in the United States District Court for the Central District of California, and docketed under 26-cv-03083, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Atara securities between May 20, 2024 and January 9, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
PICARD MEDICAL DEADLINE APRIL 3rd: Bragar Eagel & Squire, P.C. Urges Picard Medical, Inc. (NYSE:PMI) Investors to Contact the Firm Before April 3rd Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Inovio securities between October 10, 2023 and December 26, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Space Station, Inc.and Certain Officers – GEMI
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02261, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Gemini Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”); and/or Gemini securities between September 12, 2025 and February 17, 2026, both dates inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 11 and 15 of the Securities Act of 1933 (the “Securities Act”) and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
IGEL Partners with Exclusive Networks to Expand Its Security Channel Ecosystem
Agreement strengthens IGEL’s security-led distribution strategy and channel reach, while leveraging Exclusive Networks’ CyberLAB validation environment to enhance partner enablement
By IGEL · Via GlobeNewswire · March 31, 2026
Bragar Eagel & Squire, P.C. Reminds Stockholders That Class Action Lawsuits Have Been Filed Against Lakeland and Zynex and Encourages Investors to Contact the Firm
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lakeland Industries, Inc. (NASDAQ: LAKE) and Zynex, Inc. (OTCPK: ZYXIQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Plug Power Inc. and Certain Officers – PLUG
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Plug Power Inc. (“Plug Power” or the “Company”) (NASDAQ: PLUG) and certain officers. The class action, filed in the United States District Court for the Northern District of New York, and docketed under 26-cv-00165, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Plug Power securities between January 17, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
RICHTECH ROBOTICS DEADLINE FRIDAY: Bragar Eagel & Squire, P.C. Urges Richtech Robotics Inc. Investors with Large Losses to Contact the Firm Before April 3rd
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Richtech (RR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2026
Old National Bancorp Announces Schedule for First-Quarter Earnings Release and Conference Call
EVANSVILLE, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Old National Bancorp (“Old National”), the holding company of Old National Bank, today announced the following schedule for its first-quarter earnings release and conference call:
By Old National Bancorp · Via GlobeNewswire · March 31, 2026
Native Voices Matter in Primaries and Midterms. REGISTER NOW!
Make Native Voices Heard in Every Election
By American Indian College Fund · Via GlobeNewswire · March 31, 2026
Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc.
DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management:
By Pineal Capital Management · Via GlobeNewswire · March 31, 2026
Ensemble + Cohere to Deliver the First RCM-Native LLM Built for Real Healthcare Orchestration
CINCINNATI, Ohio, March 31, 2026 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading end-to-end revenue cycle managed services partner for healthcare organizations, and Cohere, a leading security-first enterprise AI company, today announced an expanded partnership to build the healthcare industry’s first revenue cycle management (RCM)-native large language model (LLM). 
By Ensemble Health Partners · Via GlobeNewswire · March 31, 2026
CareMetx Launches Next-Generation Patient Access Platform
Pharmaceutical patient services leader deploys new CRM infrastructure built on P3 Technology as part of broader evolution toward intelligence-driven patient access
By CareMetx, LLC · Via GlobeNewswire · March 31, 2026
Your Business Systems Are Making Decisions Without You
Ypifany LLC introduces the Decision Visibility Model — a new framework that shows small business owners which decisions are still running their systems, and whether they still fit
By Ypifany LLC · Via GlobeNewswire · March 31, 2026
QCI to Showcase AGI56.1 at IGA 2026, Accelerating Performance Across Tribal Gaming Operations
SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) today announced AGI56.1, a new release designed to deliver significant performance enhancements for tribal gaming operators, with a particular focus on player development workflows. QCI will showcase AGI56.1 through live demonstrations at its booth during the Indian Gaming Association (IGA) Tradeshow & Convention 2026.
By QCI · Via GlobeNewswire · March 31, 2026
As graduation and tax season near, families reconsider keeping young adults on their health plans
New insights from healthinsurance.org: The simplest option isn’t always the most affordable
By healthinsurance.org · Via GlobeNewswire · March 31, 2026
IGEL Research Quantifies 62% Endpoint IT Cost Reduction with Its Adaptive Secure Endpoint Platform
New research shows how prevention-first endpoint architecture is redefining ROI in a Zero Trust world
By IGEL · Via GlobeNewswire · March 31, 2026
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.”
By PatentVest, Inc. · Via GlobeNewswire · March 31, 2026